Key result
GII.4 Sydney strains account for ~50% of global norovirus sequences in children under five.
Why the study?
Norovirus vaccine design is challenging due to high genetic diversity and incomplete understanding of cross-protective immunity, despite noroviruses being a leading cause of pediatric acute gastroenteritis.
Observational (n=1,325)
Yes
Norovirus is a major cause of pediatric acute gastroenteritis globally, highlighting the need for effective vaccines.
Hypothesis-generating for norovirus countermeasures in young children; larger trials needed before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cannon et al. (2021) conducted an observational in Acute gastroenteritis (n=1,325). Norovirus infection was evaluated on Norovirus genotype distribution. Among 1,325 norovirus sequences from children under 5 with acute gastroenteritis globally, over 50% were GII.4 Sydney[P16] or GII.4 Sydney[P31] strains, highlighting high strain diversity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: